Results 131 to 140 of about 4,931 (189)
Association of serum zinc concentration with multiple surrogates of insulin resistance in a population-based study. [PDF]
Ghafouri-Taleghani F +4 more
europepmc +1 more source
Central insulin dysregulation in antipsychotic-naïve first-episode psychosis: In silico exploration of gene expression signatures. [PDF]
Lee J +12 more
europepmc +1 more source
FAIR and Square: Privacy Compliance Framework for Healthcare Databases
Zhu Z +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Plasma chlorpropamide: A critical factor in chlorpropamide-alcohol flush
European Journal of Clinical Pharmacology, 1983The chlorpropamide-alcohol flush (CPAF) phenomenon was quantitatively related to blood levels of acetaldehyde and chlorpropamide in 105 Type II diabetics, of whom 74 had not previously taken the drug and 31 were on chronic treatment. Standardized skin temperature recordings were made with a sensitive probe.
P, Jerntorp +4 more
exaly +3 more sources
Pediatrics, 1968
Clinical signs of hypoglycemia developed in a 3½-year-old boy 24 hours after he had eaten some of the attractively blue-colored chlorpropamide tablets. Low blood sugar values persisted for 4 days after the ingestion concomitant with an increase in serum insulin concentration. On the fifth day, the blood sugar rose to normal levels.
B, Greenberg, C, Weihl, G, Hug
openaire +2 more sources
Clinical signs of hypoglycemia developed in a 3½-year-old boy 24 hours after he had eaten some of the attractively blue-colored chlorpropamide tablets. Low blood sugar values persisted for 4 days after the ingestion concomitant with an increase in serum insulin concentration. On the fifth day, the blood sugar rose to normal levels.
B, Greenberg, C, Weihl, G, Hug
openaire +2 more sources
SEVERE CHLORPROPAMIDE TOXICITY
Journal of the American Medical Association, 1960Chlorpropamide (Diabinese) is a potent, orally used, hypoglycemic sulfonylurea derivative that recently has been used in the management of diabetes mellitus. Earlier reports 1 of clinical trials have, in general, mentioned only minimal sideeffects or none at all when the drug is used in recommended therapeutic doses.
E L, ROTHFELD +3 more
openaire +2 more sources
CHLORPROPAMIDE‐INDUCED HYPONATRAEMIA
Medical Journal of Australia, 1975A case of hyponatraemia occurring in a 69-year-old diabetic woman taking chlorpropamide is reported. Increasing the dose of chlorpropamide aggravated the hyponatraemia, and the condition corrected itself when the chlorpropamide was withdrawn. It is believed, therefore, that, in the absence of any other cause for the hyponatraemia, chlorpropamide was ...
H J, Peak, A, Horniblow
openaire +2 more sources

